The impact of computerised physician order entry on prescribing in general paediatric units in Hong Kong

Conor Ming-Ho Sin1, Mei Wan Young2, Charles Cheuk Hang Lo1

  • 1Pharmacy Department, United Christian Hospital, Kwun Tong, Kowloon, Hong Kong.

Insights

Computerised Physician Order Entry (CPOE) systems significantly reduced medication prescribing errors in a Hong Kong paediatric unit. While eliminating handwriting errors, CPOE introduced new error types, highlighting the need for careful system design and training.

Area of Science:

  • Medical Informatics
  • Paediatric Pharmacy
  • Health Systems Research

Background:

  • Medication prescribing errors pose a significant risk in paediatric care.
  • Computerised Physician Order Entry (CPOE) systems are implemented to improve medication safety.
  • Evaluating the impact of CPOE on prescribing errors is crucial for optimizing healthcare delivery.

Purpose of the Study:

  • To assess the effect of a closed-loop CPOE system on medication prescribing errors in a Hong Kong paediatric unit.
  • To analyze changes in the characteristics of prescribing errors before and after CPOE implementation.

Main Methods:

  • A single-site, prospective, observational study was conducted in a public hospital's general paediatric unit.
  • Data on medication orders and prescribing errors were collected pre- and post-CPOE implementation (March-April 2019 and 2020).
  • Error characteristics analyzed included severity, patient age group, drug formulation, and drug class.

Main Results:

  • The prescribing error rate decreased significantly from 6.7% to 3.9% post-CPOE implementation.
  • Handwriting-related errors were eliminated, and dosage selection errors were reduced.
  • New error types emerged, including missing patient information, potentially delaying medication dispensing.

Conclusions:

  • CPOE systems demonstrably reduce prescribing errors and modify error profiles in paediatric settings.
  • System design flaws and insufficient user training can introduce novel errors.
  • Optimizing CPOE implementation requires attention to user training and system interface design to maximize safety benefits.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
115
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
83
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
83
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
90
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
90
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.6K